doi:10.1021/jf503257w 42
References Alvarez MC, Albuquerque MLL, Neiva HP, Cid L, Rodrigues F, Teixeira DS, Matos R, Antunes R, Morales-Snchez V, Monteiro D
Primary human pancreatic PDAC024T, PDAC030T, PDAC053T, PDAC054T, PDAC084T, PDAC090T and PDAC211T cells were grown in serum-free ductal medium DMEM/F12 (Gibco, 10565018) supplemented with 0.61 g in 500 ml nicotinamide (Sigma-Aldrich, 3376), 2.50 g in 500 ml glucose (Sigma-Aldrich, G6152), 1:200 ITS+ (Corning, 354352), 1:20 Nu-serum IV (Corning, 355104), 100 ng ml 1 cholera toxin, 1 M dexamethasone (Sigma-Aldrich, D4902), 50 nM 3,3,5-triiodo-l-thyronine (Sigma-Aldrich, T6397) and penicillinstreptomycin)
Cladribine, Idarubicin, Cytarabine (ara-C), and Venetoclax in Treating Patients with Acute Myeloid Leukemia and High-Risk Myelodysplastic Syndrome